12:00 AM
Jul 21, 2014
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

ImStem Biotechnology preclinical data

In an animal model of MS, human embryonic stem cell-derived mesenchymal stem cells (hES-MSCs) were more effective in treating MS than mesenchymal stem cells...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >